The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q2 2024 call → NOWe need to determine if management conveys that reported results for Q2 2024 do not represent the business as it is actually running today. Look for statements about current activity being ahead of the reported period. Management discusses Q2 performance and guidance for Q3. They mention exceeding guidance by $0.5M, but also mention casualty losses. They talk about strength in sulfur hauling, but slowdown in other lines. They mention marine day rates stronger and full utilization expected in Q3. They mention fertilizer seasonal trough in Q3. They mention Beryl impact on shore based terminals. They adjust CapEx for 2024. They mention ELSA project on track, oleum tower complete by end of July, start shipping mid-August, sales potential remains. They mention additional CapEx for fertilizer storage and grease business improvements. They mention leverage ratio unchanged. They mention ribbon cutting for DSM Semichem plant. The question: does management convey that reported results are stale relative to operating present? They say "Looking towards the third quarter, we continue to see day rates stronger than our original forecast and we also foresee full utilization of our marine fleet, providing the opportunity to exceed third quarter guidance." That suggests current quarter is better, but that's future guidance. They also mention sulfur production higher than forecast, but that's Q2 actual. They mention Beryl impact on shore based terminals for rest of year. They mention ELSA coming online in Q4 but not yet. They don't explicitly say that the business has already changed such that Q2 numbers are stale. They talk about expectations for Q3. The "gap" direction? They beat Q2 guidance slightly, but had casualty losses. They say "barring any unusual operating or weather events, we believe Martin Midstream's third quarter performance should approximate guidance." That suggests Q3 is expected to be in line. They mention some strengths and some weaknesses. There is no strong indication that the business as it stands today is ahead of the reported period. They discuss investments and projects, but that's normal. The only possible thing is ELSA, but it's not yet generating revenue. They also mention ribbon cutting for DSM Semichem, but that's a partnership venture, not their own. So likely NO. The call is a conventional results-and-outlook discussion.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.